ACTRN12615001118594已完成未知
Satiety and blood glucose measurement trial to determine the effects of formulated beverages with red grape skin extract in healthy adults
The New Zealand Institute for Plant & Food Research Ltd0 个研究点目标入组 30 人开始时间: 2015年10月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Healthy male and female individuals, aged 18–60 years with BMI of 18.5–26 kg/m2 (or up to 30 kg/m2 if healthy, by self-report)
排除标准
- •Pregnant women, smokers, on medication, on restrained diet, have food allergy or intolerance to soy, milk, cereals (gluten), nuts, sesame seeds.
研究者
相似试验
尚未招募
不适用
A clinical study to determine the blood glucose response in healthy volunteersCTRI/2018/06/014355Signutra Inc
尚未招募
不适用
A study on healthy people to see the effect on blood glucose levels after eating a high sugar food with fiber and to see the effect of fiber on hunger.CTRI/2015/07/006013Mr Ajay Nilawar32
招募中
4 期
A trial investigating the effect on blood glucose after the injection of fast-acting insulin aspart (Fiasp®) in comparison to insulin aspart (NovoRapid®) around exercise in participants with type 1 diabetesE10Type 1 diabetes mellitusDRKS00015855Forschungseinheit für interdisziplinäre metabolische Medizin, Medizinische Universität Graz44
进行中（未招募）
1 期
A study that investigates the effects of fast-acting insulin (FIASP®) on blood sugars in comparison to a different fast-acting insulin (NovoRapid®) around exercise in participants with type 1 diabetesMedDRA version: 20.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861Type 1 DiabetesEUCTR2019-001281-14-ATMedical University of Graz44
进行中（未招募）
不适用
Blood glucose performance testDiabetes mellitusNutritional, Metabolic, EndocrineDiabetesISRCTN11668805Abbott Diabetes Care Ltd (UK)50